PF-06293620
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06293620, covering 2018-10-16 to 2018-10-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus [Phase 1]